• HOME (current)
  • MEETINGS ARCHIVE
    2022 RANZCO 2019 RANZCO 2018 RANZCO 2017 RANZCO 2016 RANZCO 2015 RANZCO 2014 RANZCO 2013 RANZCO
  • ADVANCED SEARCH
  • 2016 RANZCO HANDBOOK
Home > 2010 RANZCO > CONCURRENT SESSIONS

Session : CONCURRENT SESSIONS


SESSION INFORMATION

Date: 21 Nov 2010

Time: 2:00 pm - 3:30 pm

Meeting: 2010 RANZCO

ABSTRACT NUMBER : 1
DELAY IN RANIBIZUMAB INJECTIONS FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
ABSTRACT NUMBER : 2
NOVEL NANOSECOND LASER TREATMENT TO PREVENT VISION LOSS FROM AGE-RELATED MACULAR DEGENERATION
ABSTRACT NUMBER : 3
CAN SYSTEMIC MARKERS OF INFLAMMATION PREDICT SUBTYPES OF AGE RELATED MACULAR DEGENERATION?
ABSTRACT NUMBER : 4
URINARY BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION
ABSTRACT NUMBER : 5
CHANGING GENETIC ASSOCIATIONS WITH AGE Ð APOE AND AGE RELATED MACULAR DEGENERATION
ABSTRACT NUMBER : 6
VARIANTS IN THE APOE GENE ARE ASSOCIATED WITH IMPROVED TREATMENT OUTCOME FOLLOWING ANTI-VEGF THERAPY FOR NEOVASCULAR AMD
ABSTRACT NUMBER : 7
A PILOT, PROSPECTIVE, RANDOMIZED CLINICAL TRIAL OF A NEW NANOPULSE RETINAL LASER VERSUS CONVENTIONAL PHOTOCOAGULATION FOR THE TREATMENT OF DIABETIC MACULAR OEDEMA
ABSTRACT NUMBER : 8
RESTORE TRIAL OF RANIBIZUMAB FOR DIABETIC MACULAR OEDEMA: 1-YEAR FINDINGS
ABSTRACT NUMBER : 9
RETINAL MICROVASCULAR SIGNS AND RISK OF INCIDENT DIABETES: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS
ABSTRACT NUMBER : 10
ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTIONS
Advanced Search

MOST VIEWED ABSTRACTS


  • This Week
  • This Month
  • All Time

    IRREVERSIBLE LENALIDOMIDE RELATED OPTIC NEUROPATHY IN A PATIENT WITH CHRONIC MYELOID LEUKAEMIA

    A cost-effectiveness analysis of AcrySof IQ vivity intraocular lens from private health fund perspective in Australia

    Efficacy and safety of intravitreal pegcetacoplan in geographic atrophy: Results from the phase 3 DERBY and OAKS trials

    Efficacy and safety of intravitreal pegcetacoplan in geographic atrophy: Results from the phase 3 DERBY and OAKS trials

    A cost-effectiveness analysis of AcrySof IQ vivity intraocular lens from private health fund perspective in Australia

    VERTICAL PRISM FUSION RANGES IN A NORMAL POPULATION

    IRREVERSIBLE LENALIDOMIDE RELATED OPTIC NEUROPATHY IN A PATIENT WITH CHRONIC MYELOID LEUKAEMIA

    A cost-effectiveness analysis of AcrySof IQ vivity intraocular lens from private health fund perspective in Australia

    A CASE OF GLAUCOMA IN HEREDITARY SPHEROCYTOSIS

RECENT MEETINGS


2022 RANZCO, 52nd Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists
25 February – 1 March 2022
Brisbane Convention & Exhibition Centre (BCEC)
2019 RANZCO, 51st Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists
08 November – 12 November 2019
Sydney, Australia

ARCHIVES

© COPYRIGHT 2016 The Royal Australian and New Zealand College of Ophthalmologists